Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Controlled, Double-blind Trial to Investigate the Effects of a New Infant Formula in Healthy Term Subjects on Growth, Body Composition, Tolerance and Safety.

NCT01609634 is registered in ClinicalTrials.gov with Danone Asia Pacific Holdings Pte, Ltd. as lead sponsor.

NCT NCT01609634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01609634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Controlled, Double-blind Trial to Investigate the Effects of a New Infant Formula in Healthy Term Subjects on Growth, Body Composition, Tolerance and Safety.
Lead sponsor
Danone Asia Pacific Holdings Pte, Ltd.
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2012
Completion date
December 31, 2019
Enrollment
541 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy